Capital Performance Advisors’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-79
Closed -$3.56K 2048
2024
Q3
$3.56K Buy
+79
New +$3.56K ﹤0.01% 1274